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INTRODUCTION
The prevalence of diabetic ketoacidosis (DKA) in children with 
type 1 diabetes mellitus (T1DM) is 30% at the time of diagnosis.1 
Cerebral edema is a rare, but life-threatening complication of DKA, 
occurring in only 0.3 - 1% of cases.2 Deep vein thrombosis and acute 
pancreatitis are other rare complications of DKA. Supraventricu-
lar tachycardia (SVT) as a complication of pediatric DKA has been 
reported.3 A unique case of a pediatric patient who had multiple rare 
complications of DKA including cerebral edema, venous thrombosis, 
and hypertriglyceridemia associated acute pancreatitis is presented. 
The SVT episode encountered during the admission was due to com-
plications arising from a procedure and not due to DKA itself.
CASE REPORT
A 17-year-old Caucasian male presented to the emergency depart-
ment (ED) due to altered mental status, Kussmaul respiration, 
hyperglycemia (serum glucose 991 mg/dl), and ketoacidosis (serum 
bicarbonate 8 mmol/L, anion gap 26, and urine ketones 4+). The 
patient was an obese (120 kg) young man with Attention Deficit 
Hyperactivity Disorder (ADHD). He had polyuria and polydipsia for 
about two weeks prior to presentation. He was seen by his primary 
care physician (PCP) and was discharged home with possibility of 
food poisoning. He did not have symptoms suggestive of dehydration 
or altered mental status during this visit. He developed cough, rhi-
norrhea, and tachypnea. His symptoms worsened over ensuing three 
days, and he presented to the ED.
The patient’s past medical history was significant for Asperger 
syndrome. Over the past six years, his weight and body mass index 
percentile had worsened from the 95th and 93rd percentile to the 
99th and 98th percentile, respectively. With obesity concerns, 
metabolic work-up was ordered by his PCP about five years prior 
to presentation. He had normal thyroid function tests, normal liver 
function tests, and normal glycosylated hemoglobin of 5.1% (normal 
< 5.7%). The only abnormal finding was a serum low-density lipopro-
tein (LDL) of 112 mg/dL (normal < 100 mg/dL). He was scheduled 
for repeat measurements of a comprehensive metabolic panel, liver 
function tests, thyroid function tests, and glycosylated hemoglobin by 
his PCP, but he missed several appointments. 
In the ED, the patient was diagnosed with new onset type 1 dia-
betes mellitus presenting with DKA. He received a total of two liters 
of normal saline bolus by the transport team and another one liter in 
the ED. He was started on an insulin drip and 1.5 times maintenance 
fluids, per institutional DKA protocol, then transferred to the pediat-
ric intensive care unit (PICU). With no improvement in mental status 
for 14 hours following admission to PICU, two doses of mannitol were 
given. Subsequently, a computerized axial tomography (CT) scan of 
the head revealed generalized cerebral edema.  
His mental status failed to improve on hospital day two despite 
improvement of his hyperglycemia and hydration status. He was 
persistently febrile (maximum temperature 38.9° Celsius) since 
admission with serum procalcitonin being 20.39 ng/ml. His serum 
white blood count was 18,600/mm3. His cerebral edema precluded 
performing a lumbar puncture. He was started on empiric ceftriaxone 
and vancomycin for meningitis concern. 
A peripherally inserted central catheter (PICC) line was insert-
ed in his left arm for antibiotic delivery and frequent blood draws. 
During insertion, he had an episode of SVT which resolved with one 
dose of adenosine and repositioning of the PICC line. His echocar-
diogram showed normal function. His electrocardiogram revealed 
a corrected QT interval of 532 msec. Serial serum troponin I levels 
were performed. His peak serum troponin I was 0.49 ng/ml, which 
normalized over one week of hospitalization without any cardiac-
specific intervention. Serial laboratory values are shown in Table 1.
Hospital days three and four were characterized by slow resolu-
tion of metabolic acidosis and improvement of mental status. Lumbar 
puncture was performed on hospital day four to guide antibiotic 
therapy. The cerebrospinal fluid findings were not concerning for 
acute bacterial meningitis. His fever also resolved by day four and 
serum procalcitonin decreased to 1.14 ng/ml.
His mental status returned to baseline on day five of hospital-
ization. He developed acute abdominal pain along with nausea and 
vomiting. His serum lipase and serum triglyceride on admission were 
585 U/L and 2605 mg/dL, respectively. When measured again on day 
five, they were 1289 U/L and 419 mg/dL, respectively. These results 
were suggestive of acute pancreatitis secondary to hypertriglyceride-
mia. He developed left upper extremity discomfort and blood draw 
from his PICC line became difficult. His upper extremity ultrasound 
showed an obstructive thrombosis of left axillary and basilic veins. 
His PICC line was removed and he was started on low molecular 
weight heparin.
On day six of hospitalization, his nausea and abdominal pain 
resolved. He was transitioned to subcutaneous insulin regimen and 
transferred to the pediatric floor for diabetes education. He was dis-
charged home on day eight of hospitalization in stable condition.
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Serum Levels 
(normal values)
Day 0
ER/
PICU
Day 1
PICU
Day 2
PICU
Day 3
PICU
Day 4
PICU
Day 5 
PICU
Day 6 
Floor
Glucose
(70-90 mg/dL) 991 391 208 164 172 158
Bicarbonate
(21-32 mmol/L) 8 12 16 20 23 26
Anion gap
(5-15 mmol/L) 26 17 13 10 6 8
Procalcitonin
(<0.25 ng/mL) 20.39 8.05 1.14
White blood cells
(5.0-10.0 k/cumm) 18.6 9.5 6.9
Troponin I
(<0.07 ng/mL) 0.42 0.31 0.12 0.49 0.22 0.02
Lipase
(73-393 Unit/L) 585 1235 1289
Triglycerides
(<150 mg/dL) 2605 554 393 419
DISCUSSION
The incidence of cerebral edema in children with DKA is low, but 
it has high mortality (24%) and high morbidity (35%).4 If cerebral 
edema occurs in a DKA patient, it is generally during the first 12 
hours after the treatment rather than before treatment, although up 
to 20% of cases of cerebral edema occur before initiation of therapy.5,6 
Common risk factors for development of cerebral edema in DKA 
patients include new onset type 1 diabetes mellitus, young age at diag-
nosis, severe acidosis, and severe dehydration.7,8
DKA usually promotes a prothrombotic state.9 A meta-analysis 
showed that deep venous thrombosis is common in adults with PICC 
line compared to central venous catheters, especially in critically ill 
patients and the ones with diagnosis of malignancy.10 Adolescents 
with underlying chronic illnesses are considered to be at the greatest 
risk to develop in-hospital deep vein thrombosis.11
Although supraventricular tachycardia in our patient was thought 
to be associated with PICC line placement, there has been a case 
report describing the occurrence of supraventricular tachycardia in 
absence of a central line.3 Elevated troponin level also has been seen 
in DKA patients. Elevated troponin level without acute coronary 
syndrome predicts higher risk for cardiac events and mortality in the 
future.12 The SVT episode in the patient presented was due to com-
plication from PICC line placement and should not be considered a 
complication of DKA.
Hypertriglyceridemia induced acute symptomatic pancreatitis has 
been described in the pediatric DKA population.13 Mild elevations in 
serum amylase and lipase are common in children with DKA. The 
suggested treatment options for severe hypertriglyceridemia induced 
pancreatitis are insulin, heparin, and/or plasmapheresis.14-16
The late presentation of our DKA patient could have attributed to 
his prolonged complicated hospitalization. His persistent fever with 
elevated white blood count and serum procalcitonin level could have 
contributed to the complicated course as well. Infection usually is 
not present in most children with DKA, and high white blood count 
reflects the severity of DKA.17 DKA is known to induce a proinflam-
matory state,18 which could have contributed to his prothrombotic 
state leading to venous thrombosis. The SVT episode encountered 
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during this admission was iatrogenic, and did not seem to be a com-
plication of DKA in this patient.
CONCLUSION
Our case illustrated multiple rare complications of DKA in a single 
pediatric patient. Although the majority of DKA patients are treated 
without complications, clinicians caring for such patients should 
anticipate a prolonged complicated course in rare instances.
REFERENCES 
1 Dabelea D, Rewers A, Stafford JM, et al. Trends in the prevalence of keto-
acidosis at diabetes diagnosis: The SEARCH for diabetes in youth study. 
Pediatrics 2014; 133(4):e938-945. PMID: 24685959.
2 Bialo SR, Agrawal S, Boney CM, Quintos JB. Rare complications of pedi-
atric diabetic ketoacidosis. World J Diabetes 2015; 6(1):167-174. PMID: 
25685287.
3 Finn BP, Fraser B, O’Connell SM. Supraventricular tachycardia as a com-
plication of severe diabetic ketoacidosis in an adolescent with new-onset type 
1 diabetes. BMJ Case Rep 2018; 2018. PMID: 29545427.
4 Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome 
of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child 
2001; 85(1):16-22. PMID: 11420189.
5 Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in 
children with diabetic ketoacidosis. The Pediatric Emergency Medicine Col-
laborative Research Committee of the American Academy of Pediatrics. N 
Engl J Med 2001; 344(4):264-269. PMID: 11172153.
6 Lawrence SE, Cummings EA, Gaboury I, Daneman D. Population-based 
study of incidence and risk factors for cerebral edema in pediatric diabetic 
ketoacidosis. J Pediatr 2005; 146(5):688-692. PMID: 15872675.
7 Wolfsdorf J, Glaser N, Sperling MA, American Diabetes Association. 
Diabetic ketoacidosis in infants, children, and adolescents: A consensus 
statement from the American Diabetes Association. Diabetes Care 2006; 
29(5):1150-1159. PMID: 16644658.
8 Dunger DB, Sperling MA, Acerini CL, et al. ESPE/LWPES consensus 
statement on diabetic ketoacidosis in children and adolescents. Arch Dis 
Child 2004; 89(2):188-194. PMID: 14736641.
9 Carl GF, Hoffman WH, Passmore GG, et al. Diabetic ketoacidosis promotes 
a prothrombotic state. Endocr Res 2003; 29(1):73-82. PMID: 12665320.
10 Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism 
associated with peripherally inserted central catheters: A systematic review 
and meta-analysis. Lancet 2013; 382(9889):311-325. PMID: 23697825.
11 Setty BA, O’Brien SH, Kerlin BA. Pediatric venous thromboembolism in 
the United States: A tertiary care complication of chronic diseases. Pediatr 
Blood Cancer 2012; 59(2):258-264. PMID: 22038730.
12 Al-Mallah M, Zuberi O, Arida M, Kim HE. Positive troponin in diabetic 
ketoacidosis without evident acute coronary syndrome predicts adverse 
cardiac events. Clin Cardiol 2008; 31(2):67-71. PMID: 18257021.
13 Nair S, Yadav D, Pitchumoni C. Association of diabetic ketoacidosis and 
acute pancreatitis: Observations in 100 consecutive episodes of DKA. Am J 
Gastroenterol 2000; 95(10):2795-2800. PMID: 11051350.
14 Tsuang W, Navaneethan U, Ruiz L, Palascak JB, Gelrud A. Hypertriglyc-
eridemic pancreatitis: Presentation and management. Am J Gastroenterol 
2009; 104(4):984-991. PMID: 19293788.
15 Betteridge DJ, Bakowski M, Taylor KG, Reckless JP, de Silva SR, Galton 
DJ. Treatment of severe diabetic hypertriglyceridaemia by plasma exchange. 
Lancet 1978; 311(8078):1368. PMID: 78139.
16 Lutfi R, Huang J, Wong HR. Plasmapheresis to treat hypertriglyceride-
mia in a child with diabetic ketoacidosis and pancreatitis. Pediatrics 2012; 
129(1):e195-e198. PMID: 22201145.
17 Flood RG, Chiang VW. Rate and prediction of infection in children with 
diabetic ketoacidosis. Am J Emerg Med 2001; 19(4):270-273. PMID: 
11447509.
18 Close TE, Cepinskas G, Omatsu T, et al. Diabetic ketoacidosis elicits 
systemic inflammation associated with cerebrovascular endothelial cell dys-
function. Microcirculation 2013; 20(6):534-543. PMID: 23441883. 
Keywords: diabetic ketoacidosis, brain edema, hyperlipidemia, supraventricular 
tachycardia, case report
90
